The NF2 & Schwannomatosis State of the Art is the biennial gathering for the NF2 and schwannomatosis professional community, bringing together clinicians, geneticists, oncologists, neurosurgeons, audiologists, biologists, and others familiar with NF2-related and other schwannomatosis to share their most recent basic research and clinical findings.
The Children's Tumor Foundation is proud to sponsor this important event, and also make available a limited number of scholarships to early stage clinicians and researchers.
State of the Art is taking place January 12-15, 2023 at the UCLA Luskin Conference Center in Los Angeles.
A free educational session is open to the patient community on Thursday, January 12 and on Sunday, January 14, CTF President Annette Bakker will speak about the future of NF2 and schwannomatosis research. Visit https://www.nf2-swn.org/soa-event for more information, the agenda, the scholarship application, and links to register.
